Mr Andreas Katopodis | Chief Executive Officer
Anaveon |

Andreas is co-founded Anaveon in April 2018, and previously was the Director of Autoimmunity, Transplantation & Inflammation, Novartis Institutes of  Biomedical Research, Basel Big Pharma experience in the discovery and development of immunomodulating drugs (26 years) Extensive BD&L experience, supported and closed multiple deals between pharma and start-ups Faculty at the Georgia Institute of Technology (5 years)